200,000 needles of "anticancer drugs" have been used by 200 patients. Can tumor cells really be eliminated?

200,000 needles of "anticancer drugs" have been used by 200 patients. Can tumor cells really be eliminated? There are three traditional methods to diagnose and treat cancer, namely, surgery, radiotherapy and chemotherapy. They are called the three axes of diagnosis and treatment of cancer. These three treatments can be accepted by most families and reimbursed by medical insurance.

However, there are many ways to treat cancer, such as targeted drugs. For a long time, many cancer patients were frightened by the high cost and even had to go to India to buy generic drugs, so there was the movie Dying.

Fortunately, some targeted drugs can also be reimbursed by medical insurance. But if you think that targeted drugs are the most expensive cancer treatment, you are wrong. What we are going to talk about today is immunotherapy of diseases.

On June 22nd, 20021,a CAR-T cell therapy product was approved for marketing in China State Administration of Medical Supplies, and it was also the first CAR-T cell therapy product approved for marketing in China. This CAR-T cell therapy product, approved for marketing by China National Medical Supplies Administration, was developed by Fosun Kate and can be used to treat second-line and above refractory large B-cell lymphoma. This medicine has attracted great attention since it came into the market, because its price is surprisingly high. The treatment cost of this CAR-T cell therapy product actually reached 654.38+0.2 million once. For billionaires, 1.2 million is nothing. But what about the average working family? I don't know. How many families can give that much money at a time?

What medicine is this? It's incredibly expensive. In fact, to be clear, CAR-T is a cutting-edge means of cancer diagnosis and treatment, not a drug. It is called chimeric antigen receptor T cell immunotherapy, and its English full name is chimericantignerceport-cell immunology. In the laboratory, professional technicians activate T cells according to genetic engineering, and install navigation and positioning equipment CAR (Malignant Tumor Chimeric Antigen Receptor) to transform the general "warrior occupation" of T cells into "super soldiers", that is, CAR-T cells. He used his own "navigation and positioning equipment car" to professionally identify cancer cells in the body and release a large number of various utility factors through immunization to achieve the effect of treating tumors. Because CAR-T is individualized treatment and its preparation technology is definitely very advanced, the cost of one-time treatment is particularly expensive.

So far, this expensive treatment has been applied to 200 patients in China. Many people will think that such expensive treatment is worthwhile if it can cure cancer. In fact, CAR-T is not useful for every kind of cancer. For example, Aquilencel developed by Fosun Kate is only suitable for the treatment of second-line and above refractory large B-cell lymphoma, and the actual effect on general cancer is not so good.